We are live on ! Find out more
SCMP

Sucampo Pharmaceuticals, Inc.
SCMP

Delisted

SCMP was delisted on the 12th of February, 2018.

Back to rankings

68 hedge funds and large institutions have $54.8M invested in Sucampo Pharmaceuticals, Inc. in 2013 Q2 according to their latest regulatory filings, with 68 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

171% more call options, than puts

Call options by funds: $19K | Put options by funds: $7K

Holders
68
Holders Change
+68
Holders Change %
–
% of All Funds
2.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
68
Increased
–
Reduced
–
Closed
–
Calls
$19K
Puts
$7K
Net Calls
+$12K
Net Calls Change
+$12K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
GIM
1
Granahan Investment Management
Massachusetts
$7.31M +$8.82M +1,111,569 New
Dimensional Fund Advisors
2
Dimensional Fund Advisors
Texas
$5.33M +$6.42M +809,800 New
NI
3
Numeric Investors
Massachusetts
$5M +$6.02M +759,369 New
BFA
4
BlackRock Fund Advisors
California
$4.78M +$5.77M +727,092 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$3.73M +$4.5M +567,577 New
TC
6
TFS Capital
Pennsylvania
$2.54M +$3.06M +385,774 New
Wells Fargo
7
Wells Fargo
California
$2.42M +$2.92M +368,005 New
NCM
8
Nantahala Capital Management
Connecticut
$2.11M +$2.54M +320,466 New
BIM
9
Bogle Investment Management
Massachusetts
$1.8M +$2.17M +273,020 New
USAA
10
United Services Automobile Association
Texas
$1.76M +$2.12M +267,000 New
BIT
11
BlackRock Institutional Trust
California
$1.56M +$1.88M +236,735 New
Renaissance Technologies
12
Renaissance Technologies
New York
$1.55M +$1.86M +235,000 New
Northern Trust
13
Northern Trust
Illinois
$1.53M +$1.84M +231,989 New
State Street
14
State Street
Massachusetts
$1.25M +$1.51M +190,267 New
CCM
15
Consonance Capital Management
New York
$1.18M +$1.43M +179,988 New
Geode Capital Management
16
Geode Capital Management
Massachusetts
$1.11M +$1.34M +168,773 New
Jacobs Levy Equity Management
17
Jacobs Levy Equity Management
New Jersey
$886K +$1.07M +134,700 New
D.E. Shaw & Co
18
D.E. Shaw & Co
New York
$856K +$1.03M +130,129 New
BCM
19
Bridgeway Capital Management
Texas
$696K +$839K +105,800 New
Bank of New York Mellon
20
Bank of New York Mellon
New York
$583K +$703K +88,566 New
CCM
21
Cadence Capital Management
Massachusetts
$497K +$600K +75,590 New
ARTA
22
A.R.T. Advisors
New York
$471K +$569K +71,691 New
SO
23
STRS Ohio
Ohio
$446K +$538K +67,790 New
Millennium Management
24
Millennium Management
New York
$390K +$470K +59,226 New
TCIM
25
TIAA CREF Investment Management
New York
$384K +$463K +58,322 New
1
2 3

SCMP Hedge Fund Activity: Q2 2013 in Review

68 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Sucampo Pharmaceuticals, Inc. (SCMP) for Q2 2013, worth a combined $54.8M.

Buyers outnumbered sellers: 68 funds opened new SCMP positions and 0 closed out — a net gain of 68 holders — while 0 added to existing stakes and 0 trimmed.

  • 68 institutional investors held Sucampo Pharmaceuticals, Inc. (SCMP) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $54.8M of Sucampo Pharmaceuticals, Inc. stock for Q2 2013.
  • 68 funds opened new Sucampo Pharmaceuticals, Inc. positions in Q2 2013 and 0 closed out, a net change of +68 holders.

Based on aggregated 13F filings for Q2 2013.